Activecare

The page describes remote patient monitoring and care coordination outside healthcare settings, with an online platform supporting telehealth and RPM revenue for providers.

The article compares the cost benefits and predicted outcomes of using mobile cardiac outpatient telemetry as first-line monitoring after cryptogenic stroke, followed by an implantable loop recorder, with implantable loop recorder monitoring alone.

BioTelemetry, Inc. ranked 31st on Fortune Magazine’s 100 Fastest-Growing Companies list for 2019.

BioTelemetry, Inc. scheduled its first-quarter 2018 earnings release for April 25 at 4 p.m. Eastern and a conference call at 5 p.m. Eastern.

Geneva Health Solutions released cardiac device data findings at the 2019 Heart Rhythm Society conference.

BioTelemetry describes career opportunities focused on improving patient health and a learning culture that supports employees’ skills, collaboration, and customer focus.

A retrospective analysis presented at ACC.23 in New Orleans compares the diagnostic yield of 24-hour Holter monitoring with 7- and 14-day Philips extended Holter (ePatch) monitoring.

BioTelemetry says its products monitor 4 billion heartbeats daily and reach more than 1 million lives each year.

Philips Ambulatory Monitoring and Diagnostics offers connected monitoring and diagnostic solutions and services for patients and providers across the care continuum.

Philips Ambulatory Monitoring & Diagnostics and its listed companies state that they recognize the importance of protecting personal and health information, including medical and individually identifiable information.